Lumida
/IVVD
⌘K
Invivyd Inc

Invivyd Inc

IVVD
$0.79USD+1.24%+0.01 today

MARKET CAP

231.5M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
Sell NowHigh

The stock IVVD is in a Stage 4 decline with a confirmed series of lower highs and lower lows below declining EMAs, supported by distribution volume dominance. Medium-term directional bias is bearish, and near-term pullbacks into the 9/21 EMAs create favorable sell-side entry opportunities. While RSI shows extreme oversold readings, the lack of mean-reversion eligibility and failure of rallies at EMAs suggest downward momentum remains intact. We recommend immediate bearish engagement at resistance zones around the 9/21 EMAs.

  • Pemgarda net revenue rose 21% YoY to $14.3M in Q2 2026.
  • $226.7M cash position supports Phase III VYD2311 trial.
  • FDA flagged mixed third-party data in Pemgarda fact sheet.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2024FY 2025TREND
Sales, Adj.$25.4M$53.4M
YoY %+110.5%
P / Sales2.1x8.0x
EV / Sales1.8x4.4x
Gross Profit, Adj.$23.8M$49.7M
YoY %+109.0%
Margin %93.6%93.0%
EV / Gross Profit1.9x4.7x
EBITDA, Adj.$-175.4M$-54.8M
YoY %+17.4%+68.8%
Margin %-691.0%-102.6%
EV / EBITDA-0.3x-4.3x
EBIT$-176.9M$-55.6M
YoY %+16.9%+68.6%
Margin %-696.8%-104.0%
EV / EBIT-0.3x-4.2x
Net Income$-169.9M$-52.5M
YoY %+14.5%+69.1%
Net Margin-669.4%-98.2%
EPS (GAAP)-$1.43-$0.30
YoY %+21.0%+79.0%